|
PPCB Propanc Biopharma Inc 1517681 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-6,360,336.00 |
| Balance Sheet |
|
Current Assets
|
$8,223,488.00 |
|
Assets
|
$14,333,780.00 |
|
Current Liabilities
|
$3,475,628.00 |
|
Liabilities
|
$3,505,895.00 |
|
Equity
|
$9,827,885.00 |
|
Shares Out
|
21859281.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,080,653.00 |
|
Investing Cash Flow
|
$-4,912.00 |
| Market Analysis |
Market Cap
|
$22,733,652.24 |
|
Price
|
$1.05 |
|
BVPS
|
0.45 |
|
PB
|
2.31 |
|
EPS
|
-0.28 |
|
FCF
|
$-4,085,565.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PPCB documents filed with the SEC.
PPCB Filings
Clear
